VANI Vivani Medical Inc.
Company Analysis
Latest News
🟢 Vivani Medical is trading 5% up today amid biotech strength
Vivani Medical is trading 5.15% higher at $1.43, mainly in line with biotech strength as XBI rises 2.75%. - No new company-specific announcement was...
🔴 Vivani Medical is trading 5% down today with no confirmed catalyst identified
Vivani Medical is trading 5.17% down at $1.38, with no confirmed catalyst identified. - No new company-specific announcement dated August 19, 2026, was...
🟢 Vivani Medical is trading 5% up today; no clear catalyst identified
Vivani Medical is trading 5% up at $1.42, based on live price context for August 18, 2026; the stock-specific gain remains unexplained. - No major...
🟢 Vivani Medical is trading 5.38% up in pre-market after narrower Q2 loss
Vivani Medical is trading 5.38% up in pre-market at $1.41 after August 13, 2026, second-quarter results showed a narrower $6.4 million net loss and quarterly...
Vivani Medical narrows second quarter 2026 loss to $6.4M as NPM-139 clinical trial dosing completes
Vivani Medical reported a net loss of $6.4 million for the second quarter of 2026, a slight improvement from the $7.1 million loss in the same period last...
🔴 Vivani Medical is trading 5.7% down in pre-market — no clear company-specific catalyst identified
Vivani Medical is trading 5.7% down at $1.33 in pre-market after closing at $1.41 on August 10, 2026; no clear company-specific catalyst was identified for the...
Vivani Medical Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Analysts expect Vivani Medical to report a loss of $0.08 per share on zero revenue for Q2 2026, with the stock currently trading near $1.40 against a consensus...
🟢 Vivani Medical is trading 5% up today after completing dosing for all 20 SLIM-1 participants
Vivani Medical is trading 5.15% up now at $1.43 after announcing on August 6, 2026, that all 20 participants had been dosed in its SLIM-1 Phase 1 trial of...
Vivani Medical Completes Participant Dosing in Phase 1 Trial for Semaglutide Implant
Vivani Medical announced it has successfully completed the initial dosing of all 20 participants in its SLIM-1 Phase 1 clinical trial. The trial is evaluating...
🟢 Vivani Medical is trading 5.3% up today amid broad market and biotech sector gains
Vivani Medical is trading 5.3% up at $1.40 amid a broad risk-on rally in U.S. equities and strength in biotech peers. • The move aligns with macro momentum as...
🟢 Vivani Medical is trading 5.1% up today on broader risk-on sentiment and easing geopolitical tensions
Vivani Medical is trading 5.1% up at $1.34, rebounding from last week’s pullback and modestly extending its late-July gains. • The move appears driven by...
🔴 Vivani Medical is trading 5.4% down today amid small-cap volatility and a lack of news
Vivani Medical is trading 5.4% down today at $1.31 amid broader small-cap volatility and a lack of fresh company-specific news. • The move appears to be a...
🟢 Vivani Medical Inc. is trading 5.93% up
VANI is trading at $1.43, up 5.93%.
Vivani Medical Eyes $3.50 Target, Validated by Novo Nordisk Deal
H.C. Wainwright reiterated a Buy rating for Vivani Medical, Inc. on July 10, 2026. The firm maintained a $3.50 price target for the company. This action...
🔴 Vivani Medical is trading 12.2% down
Vivani Medical is trading at $1.37, down 12.2% from a comparison close of $1.56 during regular trading. This is a price-action follow-up, so a separate...
🔴 Vivani Medical is trading 5.6% down today on profit-taking following Novo Nordisk-driven rally
Vivani Medical is trading 5.6% down today at $1.47 as short-term traders lock in gains following a sharp multi-day rally. • The recent surge was driven by the...
🔴 Vivani Medical is trading 6.6% down today on profit-taking after its recent rally
Vivani Medical is trading 6.6% down at $1.46 in pre-market as investors lock in gains following a significant price surge. • The stock is extending a...
🔴 Vivani Medical is trading 6.25% down today on profit-taking after its recent rally
Vivani Medical is trading at $1.50 (-6.25%) as investors take profits following a significant rally triggered by recent collaboration news. • Shares are...
🟢 VANI makes sharp 15.2% jump
VANI is trading at $1.55, up 15.2% versus the comparison close of $1.35 during regular trading. This is a price-movement alert; no separate company-specific...
Vivani's Novo Nordisk Deal Sparks a 19% Weekly Run — But Can a $116 Million Micro-Cap Really Ride the GLP-1 Wave?
Shares of Vivani Medical (VANI) surged 7.8% to $1.46 on July 8, extending a blistering five-session rally of roughly 19% from $1.23, after the company...